SLCO1B3 and neoplasm: While ct-SLCO1B3 has been previously investigated as an EV-derived tumor marker in both squamous cell carcinoma and colorectal cancer 6, 7, its role as a potential liquid biopsy EV-derived marker in prostate cancer has yet to be explored.